Key result
Left atrial appendiceal cannulation bridges ~88% of select pediatric patients to heart transplant.
Why the study?
Patients with preserved left ventricular size or function pose anatomic and physiologic challenges for ventricular assist device implantation due to ventricular competition, and alternative left atrial cannulation has been associated with thrombosis, obstruction, and inadequate support.
Does left atrial appendiceal cannulation using a ringed expanded polytetrafluoroethylene interposition graft safely bridge pediatric patients with preserved left ventricular size or function to transplantation?
Cohort (n=8)
No
Does left atrial appendiceal cannulation using a ringed expanded polytetrafluoroethylene interposition graft safely bridge pediatric patients with preserved left ventricular size or function to transplantation?
A novel left atrial appendiceal cannulation technique using a ringed expanded polytetrafluoroethylene interposition graft enabled 87.5% survival to transplantation without permanent neurologic complications in pediatric VAD patients with preserved left ventricular size or function.
Answers are grounded in this paper and cite their sources.
May support left atrial appendiceal cannulation for bridging in select pediatric VAD recipients with preserved ventricular size; leaves open confirmation in larger prospective studies.
Objective(s) Patients with preserved left ventricular size or function pose anatomic and physiologic challenges for ventricular assist device implantation due to ventricular competition. In these circumstances, left atrial cannulation can be performed instead of the standard apical cannulation of the ventricle. However, left atrial cannulation has been associated with thrombosis, obstruction, and inadequate support. We describe a left atrial cannulation technique using a ringed expanded polytetrafluoroethylene interposition graft tunneled through the left atrial appendage that mitigates these risks. We also discuss the adoption of routine biventricular support for patients with restrictive cardiomyopathy and a staged device strategy to optimize management. Methods Retrospective single-center review of patients undergoing left atrial appendiceal cannulation for mechanical circulatory support between June 2020 and August 2025. Results 7 of 8 (87.5%) patients survived to transplant after a median of 142 days (IQR 67-280). Five patients required biventricular assist device support. Two of three patients were successfully converted from continuous flow to pulsatile support. Three patients required reoperation prior to transplant, with one necessitating modifications to the surgical technique. Although adverse events were ubiquitous, no permanent neurologic complications were observed. Conclusions Despite high morbidity, patients with preserved left ventricular size or function can be bridged to transplantation with low mortality through a novel left atrial cannulation technique. A staged device strategy with initial continuous-flow support may afford better atrial decompression in the immediate postoperative period while allowing titration of flows to account for ventricular competition. Patients with restrictive cardiomyopathy may benefit from biventricular support.
No takes yet. Share an insight, caveat, or question.
Kaniuk et al. (2026) conducted a cohort in Pediatric patients on ventricular assist device support with preserved left ventricular size or function (including restrictive cardiomyopathy) (n=8). Left atrial appendiceal cannulation using a ringed expanded polytetrafluoroethylene interposition graft tunneled through the left atrial appendage was evaluated on Survival to cardiac transplantation. Left atrial appendiceal cannulation with a ringed ePTFE graft bridged 87.5% (7/8) of pediatric patients with preserved LV size or function to transplant after a median of 142 days.
Synapse has enriched 10 related papers. Consider them for comparative context: